Saint Gely du Fesc, France

Natalio Vita



Average Co-Inventor Count = 4.5

ph-index = 2

Forward Citations = 30(Granted Patents)


Location History:

  • Toulouse, FR (1995)
  • Saint Orens, FR (1999)
  • Montgiscard, FR (2000 - 2011)
  • Saint Gely du Fesc, FR (2012)

Company Filing History:


Years Active: 1995-2012

Loading Chart...
Loading Chart...
6 patents (USPTO):Explore Patents

Title: The Innovations of Natalio Vita

Introduction

Natalio Vita is a prominent inventor based in Saint Gely du Fesc, France. He has made significant contributions to the field of biotechnology, particularly in the development of antibodies and polypeptides. With a total of six patents to his name, Vita's work has the potential to impact various medical applications.

Latest Patents

One of his latest patents involves IL-13 receptor antibodies. This invention relates to monoclonal and polyclonal antibodies capable of specifically recognizing the IL-13 receptor α and their uses. Another notable patent is for purified polypeptides having IL-13 receptor activity. This invention pertains to a purified polypeptide comprising an amino acid sequence chosen from the sequence SEQ ID NO:4 or biologically active amino acid sequences derived from SEQ ID NO:4.

Career Highlights

Throughout his career, Natalio Vita has worked with several notable companies, including Sanofi and Société Anonyme: Elf Sanofi. His experience in these organizations has allowed him to refine his skills and contribute to groundbreaking research in his field.

Collaborations

Vita has collaborated with esteemed colleagues such as Pascual Ferrara and Daniel Caput. These partnerships have fostered innovation and have been instrumental in advancing their shared research goals.

Conclusion

Natalio Vita's contributions to biotechnology through his patents and collaborations highlight his role as a significant inventor in the field. His work continues to pave the way for advancements in medical science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…